Department of Neuropeptides, Mossakowski Medical Research Institute Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Poland.
Int J Mol Sci. 2022 Mar 2;23(5):2766. doi: 10.3390/ijms23052766.
One of the strategies in the search for safe and effective analgesic drugs is the design of multitarget analgesics. Such compounds are intended to have high affinity and activity at more than one molecular target involved in pain modulation. In the present contribution we summarize the attempts in which fentanyl or its substructures were used as a μ-opioid receptor pharmacophoric fragment and a scaffold to which fragments related to non-opioid receptors were attached. The non-opioid 'second' targets included proteins as diverse as imidazoline I binding sites, CB cannabinoid receptor, NK tachykinin receptor, D dopamine receptor, cyclooxygenases, fatty acid amide hydrolase and monoacylglycerol lipase and σ receptor. Reviewing the individual attempts, we outline the chemistry, the obtained pharmacological properties and structure-activity relationships. Finally, we discuss the possible directions for future work.
在寻找安全有效的镇痛药物的策略中,一种方法是设计多靶标镇痛药。这类化合物旨在与参与疼痛调节的多个分子靶标具有高亲和力和高活性。在本综述中,我们总结了将芬太尼或其亚结构用作μ-阿片受体药效团片段和骨架,然后将与非阿片受体相关的片段连接到其上的尝试。非阿片类“第二”靶标包括多种多样的蛋白质,如咪唑啉 I 结合位点、CB 大麻素受体、NK 速激肽受体、D 多巴胺受体、环氧化酶、脂肪酸酰胺水解酶和单酰基甘油脂肪酶以及 σ 受体。在回顾各个尝试时,我们概述了化学、获得的药理学性质和构效关系。最后,我们讨论了未来工作的可能方向。